Skip to the page

Data / Form D filings / BobcatBio, Inc.

BobcatBio, Inc.: Form D filings

BobcatBio, Inc., a biotechnology company in Hummelstown, PA, filed 4 Form D notices with the SEC between 2021 and 2025. The latest, on March 12, 2025, reports $5.3 million sold of a $15 million offering to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1214 RESEARCH BOULEVARD, SUITE 2010, Hummelstown, PA, 17036
Phone
(610) 321-3111
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1876657

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 12, 2025New notice$15,000,000$5,340,751$9,659,24911Feb 26, 2025sec.gov
Jan 22, 2024Amendment$42,099,514$27,099,514$15,000,00010Jul 23, 2021sec.gov
Nov 18, 2022Amendment$27,299,517$13,040,830$14,258,68710Jul 23, 2021sec.gov
Aug 5, 2021New notice$25,121,024$6,221,031$18,899,9936Jul 23, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Roger C. SawhneyDirector
Tim C. Van TreurenDirector
Rifat C. PamukcuDirector
Stephen C. RocamboliExecutive Officer, Director
Robert C. TowarnickiDirector

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Mar 10, 2025 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what BobcatBio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.